WuXi AppTec at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
WuXi AppTec takes part in 3 sessions at ACT 2026 in San Antonio, and exhibits at Booth 402. Its program centres on nonclinical safety packages for global filings, including how China GLP toxicology studies fit global expectations and IND-enabling studies for antibodies, antibody-drug conjugates and bispecifics. It also reviews tissue findings after nasal saline dosing across species.
| Organization | ACT 2026 Attendance |
|---|---|
WuXi AppTec St. Paul, MN | ◆Diamond Supporter |
Global contract research, development and manufacturing company; its US lab testing division runs toxicology and IND-enabling studies, including for complex biologics. | Booth Exhibiting at Booth 402 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Talk Mon Nov 16 9:40am–10:15am Talk Mon Nov 16 12:00pm–12:55pm |
Instantly find 20 buyers from WuXi AppTec
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction